Skip to main content

Advertisement

Log in

Inflammatory markers in chronic kidney disease and end stage renal disease patients

  • Original Article
  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Background

Chronic kidney disease (CKD) is condition characterized by a gradual loss of kidney function, patient with CKD suffering from a variety of immune system defects.

Methods

This study looked at Fas, T cell, BCl2, and P53 activity in people with CKD, end stage renal disease (ESRD), and stable controls.

Results

The CD4+ and CD8+ levels in ESRD patients’ peripheral blood were slightly lower than those in CKD patients. The CKD and ESRD groups had slightly higher Fas and FasL mRNA expression and slightly lower BCl2 mRNA gene expression than the normal control group (P < 0.05). P53 mRNA gene expression was shown to be higher in the patients than in the controls (P < 0.01).

Conclusions

ESRD patients have a significantly lower number of T-cell subsets than CKD patients this is related to a higher degree of apoptosis in these cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

The datasets used during the present study are available from the corresponding author on reasonable request.

Abbreviations

CKD:

Chronic kidney disease

ESRD:

End-stage renal disease

GFR:

Glomerular filtration rate

CRP:

C-reactive protein

References

  1. Kalkidan A, Misra A, Fedlu A, Getachew A, Mohamed M, Mohamed Y, Habtam H, Tefera B (2021) Consequence of exposure to prenatal famine on estimated glomerular filtration rate and risk of chronic kidney disease among survivors of the great ethiopian famine (1983–85): a historical cohort study. Nutr J. https://doi.org/10.1186/s12937-021-00675-8

    Article  Google Scholar 

  2. Zhao M, Yu Y, Wang R, Chang M, Ma S, Qu H, Zhang Y (2021) Mechanism in chronic kidney disease. Front Pharmacol 11:619201. https://doi.org/10.3389/fphar.2020.619201

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Elahi W, Syed AZ, Nasim F, Anwar A, Hashmi AA (2020) Hepatitis B and C infections in patients with prolonged hemodialysis secondary to chronic renal failure. Cureus 12(10):10905. https://doi.org/10.7759/cureus.10905

    Article  Google Scholar 

  4. Hartzell S, Bin S, Cantarelli C, Haverly M, Manrique J, Angeletti A, Manna G, Murphy B, Zhang W, Levitsky J, Gallon L, Yu SM, Cravedi P (2020) Kidney failure associates with Tcell exhaustion and imbalanced follicular helper T cells. Front Immunol 11:583702. https://doi.org/10.3389/fimmu.2020.583702

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Jia C, Luan Y, Li X, Zhang X, Li C (2021) Effects of periodontitis on postoperative pneumonia in patients with lung and esophageal cancer. Thorac Cancer 6:768–774. https://doi.org/10.1111/1759-7714.13828

    Article  CAS  Google Scholar 

  6. Thomas E, Ognian N, Anna W, Karolina K, Peter S, Paul S (2021) Inflammation and oxidative stress in CKD and dialysis patients. Antioxid Redox Signal 10:1089. https://doi.org/10.1089/ars.2020.8184

    Article  Google Scholar 

  7. Basso PJ, Andrade-Oliveria V, Camara NOS (2021) Targeting immune cell metabolism in kidney diseases. Nat Rev Nephrol. https://doi.org/10.1038/s41581-021-00413-7

    Article  PubMed  Google Scholar 

  8. Obeng E (2021) Apoptosis (programmed cell death) and its signals—a review. Braz J Biol 81(4):1133–1143. https://doi.org/10.1590/1519-6984.228437

    Article  CAS  PubMed  Google Scholar 

  9. Nazari M, Javandoost E, Talebi M, Movassaghpour A, Soleimani M (2021) Platelet microparticle controversial role in cancer. Adv Pharm Bull 11(1):39–55. https://doi.org/10.34172/apd.2021.005

    Article  CAS  PubMed  Google Scholar 

  10. Schleicher RI, Reichenbach F, Kraft P (2015) Platelets induce apoptosis via membrane-bound FasL. Blood. https://doi.org/10.1182/blood-2013-12-544445

    Article  PubMed  PubMed Central  Google Scholar 

  11. Casamayor-Polo L, Lopez-Nevado M, Paz-Artal E, Alberto A, Ferseric RL, Luis A (2020) Immunologic evaluation and genetic defects of apoptosis in patients with autoimmune lymphoproliferative syndrome (ALPS). Crit Rev Clin Lab Sci. https://doi.org/10.1080/10408363.2020.1855623

    Article  PubMed  Google Scholar 

  12. Karpuzoglu EM, Kisla Ekinic RM, Balci S, Bisgin A, Yilmaz M (2021) Altered expression of apoptosis related, circulating cell-free miRNAs in children with familial Mediterranean fever: a cross-sectional study. Rheumatol Int 41(1):103–111. https://doi.org/10.1007/s00296-020-04541-4

    Article  CAS  PubMed  Google Scholar 

  13. Betjes MG (2020) Uremia-associated ageing of the thymus and adaptive immune responses. Toxins 12:224. https://doi.org/10.3390/toxins12040224

    Article  CAS  PubMed Central  Google Scholar 

  14. Lalramenga PC, Gupta S, Naveen P (2019) Study of C-reactive protein significance in chronic kidney disease. Int J Contemp Med Res 6(6):22–25. https://doi.org/10.21276/ijcmr.2019.6.6.48

    Article  Google Scholar 

  15. Abdel-Messeih PL, Alkady MM, Nosseir NM, Tawfik MS (2020) Inflammatory markers in end-stage renal disease patients on haemodialysis. J Med Biochem 39(4):481–487. https://doi.org/10.5937/jomb0-25120

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Peters FS, Peeters AMA, Mandaviya PR (2018) Differentially methylated regions in T cells identify kidney transplant patients at risk for de novo skin cancer. Clin Epigenet 10:81. https://doi.org/10.1186/s13148-018-0519-7

    Article  CAS  Google Scholar 

  17. Xiaoyan J, Rongyi C, Xuesen C (2019) The difference of T cell phenotypes in end stage renal disease patients under different dialysis modality. BMC Nehrol 20:301. https://doi.org/10.1186/s12882-019-1475-y

    Article  CAS  Google Scholar 

  18. Akchurin O, Meza K, Biswas S, Greenbaum M, Licona-Freudenstein AP, Goyal P, Choi JJ, Cgoi ME (2021) COVID-19 in patients with CKD in New York City. Kidney 360 2(1):63–70. https://doi.org/10.3406/KID.0004142020

    Article  PubMed  Google Scholar 

  19. Mohamed AA, Khater SI, Arisha AH, Metwally MM, Hedeab GM, El-Shetry SE (2021) Chitosan-stabilized selenium nanoparticles alleviate cardio-hepatic damage in type 2 diabetes mellitus model via regulation of caspase, Bax/Bcl-2, and Fas/FasL-pathway. Gene 768:145288. https://doi.org/10.1016/j.gene.2020.145288

    Article  CAS  PubMed  Google Scholar 

  20. Olaposi O, Ukwenya V, Oyekanmi N, Alaba G, Oluwamodupe E, Inyang O (2021) Synergistic erythropoietic mechanisms of Chromolaena odorata and Tithonia diversifolia in the bone marrow of Wistar rats. Comp Clin Pathol. https://doi.org/10.1007/s00580-021-03216-1

    Article  Google Scholar 

  21. Sayequa D (2021) Mechanisms adopted by cancer cells to escape apoptosis—a review. Biocell. https://doi.org/10.32604/biocell.2021.013993

    Article  Google Scholar 

  22. Fairlie WD, Lee EF (2021) Co-operativity between MYC and BCL-2 proteins in cancer. Int J Mol Sci 22:2841. https://doi.org/10.3390/ijms22062841

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Nourie N, Chamaa MA, Mouawad S (2021) Effective treatment with Tocilizumab in ACOVID-19 patient on maintenance hemodialysis: a case report. CEN Case Rep. https://doi.org/10.1007/s13730-021-00577-y

    Article  PubMed  PubMed Central  Google Scholar 

  24. Mengwu P, Christine B (2021) Regulation of P53 by E3s. Cancers 13:745. https://doi.org/10.3390/cancers13040745

    Article  CAS  Google Scholar 

  25. Xie H, Ma K, Zhang K (2021) Cell-cycle arrest and senescence in TP53-wild type renal Carcinoma by enhancer RNA-P53-bound enhancer regions 2 (p53BER2) in a p53-dependent pathway. Cell Death Dis 12(1):1–5. https://doi.org/10.1038/s41419-020-03229-8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This research received no external funding.

Author information

Authors and Affiliations

Authors

Contributions

MMZ and SAD contributed to conception and design of the study. FME-T and SAD and AES, contributed to acquisition, analysis and interpretation of the data and writing the manuscript. MMZ, AEE-A and FME-T discussed the results and implications and commented on the manuscript at all stages, as well as in the final approval of the version to be published.

Corresponding author

Correspondence to Fatma M. El-Tantawy.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies were in accordance with ethics standards of Mansoura University, Faculty of Medicine. We commit to provide Photocopy of consent forms of all subjects involved to the ethical committee when requested before publishing or submitting to refereeing.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zakaria, M.M., Derbala, S.A., Salem, A.E. et al. Inflammatory markers in chronic kidney disease and end stage renal disease patients. Mol Biol Rep 48, 6857–6862 (2021). https://doi.org/10.1007/s11033-021-06684-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-021-06684-4

Keywords

Navigation